Cargando…
Novel pharmacotherapy: NNI-362, an allosteric p70S6 kinase stimulator, reverses cognitive and neural regenerative deficits in models of aging and disease
Aging is known to slow the neurogenic capacity of the hippocampus, one of only two mammalian adult neurogenic niches. The reduction of adult-born neurons with age may initiate cognitive decline progression which is exacerbated in chronic neurodegenerative disorders, e.g., Alzheimer’s disease (AD). W...
Autores principales: | Sumien, Nathalie, Wells, Matthew S., Sidhu, Akram, Wong, Jessica M., Forster, Michael J., Zheng, Qiao-Xi, Kelleher-Andersson, Judith A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7805132/ https://www.ncbi.nlm.nih.gov/pubmed/33436007 http://dx.doi.org/10.1186/s13287-020-02126-3 |
Ejemplares similares
-
One-Pot Preparation of HTPB/nNi and Its Catalyst for AP
por: Bao, Shuxia, et al.
Publicado: (2022) -
Pathways of allosteric regulation in Hsp70 chaperones
por: Kityk, Roman, et al.
Publicado: (2015) -
Pharmacotherapy for Nocturia
por: Andersson, Karl-Erik, et al.
Publicado: (2018) -
Answer to the question 2 from page 362
Publicado: (2012) -
PSAT362 Hypothyroidism Associated Colonic Rupture
por: Seetharaman, Karthik, et al.
Publicado: (2022)